Kowa Company, Ltd.: Hypercholesterolemia trials

The registry lists 11 Hypercholesterolemia studies with Kowa Company, Ltd. as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 3 10Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to StatinsRecruitingNCT07634484Phase 4
• Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk FactorsCompletedNCT00344175Phase 3Results posted
• Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined DyslipidemiaCompletedNCT00330876Phase 3Results posted
• Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined DyslipidemiaCompletedNCT00325780Phase 3Results posted
• Study to Compare the Efficacy and Safety of Pitavastatin and SimvastatinCompletedNCT00309777Phase 3Results posted
• Study to Compare the Efficacy and Safety of Pitavastatin and SimvastatinCompletedNCT00309738Phase 3Results posted
• Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly PatientsCompletedNCT00257686Phase 3Results posted
• Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol LevelsCompletedNCT00249249Phase 3Results posted
• A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin IntoleranceCompletedNCT05923281Phase 3
• K-924 Phase III Long Term StudyCompletedNCT04289662Phase 3
• K-924 Phase III Confirmatory StudyCompletedNCT04289649Phase 3